We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to...See more
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2016 (10 years)
Address:
33 BROADWICK STREET; LONDON, ENGLAND W1F 0DQ, GB
At a glanceHIGH
spending power
